Skip to main content
    C

    Core Laboratories NV (CLB)

    Official site

    ENERGY • OIL & GAS EQUIPMENT & SERVICES • NYSE

    $8.46
    -0.65 (-7.13%)

    Market Cap: $417.45M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Core Laboratories NV (CLB) Financials: Revenue, Profit and Cash Flow

    Updated Oct 28, 2026. Financial statements from company filings, amounts in US dollars.

    Core Laboratories NV reported revenue of $526.52M for the fiscal year ended Dec 31, 2025, up 0.5% from the year before. That year, net income was $29.67M with a net margin of 5.6%, operating cash flow was $37.03M and free cash flow was $22.29M. The quarter ended Sep 30, 2026 had revenue of $132.08M and net income of $5.44M.

    Revenue and Margins

    The operating margin was 9.6% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue fell from $594.74M, a compound annual decline of 1.3%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$526.52M+0.5%17.9%9.6%5.6%
    Dec 2024$523.85M+2.8%16.9%11.2%6.0%
    Dec 2023$509.79M+4.1%18.4%10.7%7.2%
    Dec 2022$489.74M+4.1%16.1%8.5%4.0%
    Dec 2021$470.25M-3.5%17.8%9.6%4.2%
    Dec 2020$487.27M-27.1%21.0%-15.8%-20.0%
    Dec 2019$668.21M-4.7%25.8%14.5%15.3%
    Dec 2018$700.85M+6.2%25.8%16.9%11.3%
    Dec 2017$659.81M+10.9%24.3%17.0%12.6%
    Dec 2016$594.74MN/A21.1%14.5%10.7%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income fell 5.5% from the year before. In the quarter ended Sep 2026, net income fell 61.8% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$526.52M$523.85M$509.79M$489.74M$470.25M$487.27M$668.21M$700.85M$659.81M$594.74M
    Cost of revenue$432.24M$435.48M$415.74M$410.82M$386.41M$385.14M$495.58M$520.05M$499.18M$469.52M
    Gross profit$94.28M$88.37M$94.05M$78.92M$83.84M$102.13M$172.63M$180.79M$160.63M$125.22M
    Operating income$50.49M$58.56M$54.64M$41.52M$45.26M-$76.81M$96.68M$118.62M$112.44M$86.18M
    Net income$29.67M$31.40M$36.67M$19.45M$19.73M-$97.64M$101.98M$79.53M$83.13M$63.90M
    EBITDA$71.12M$73.51M$70.42M$58.69M$63.78M$70.49M$124.62M$141.71M$134.49M$113.05M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$132.08M$124.61M$121.80M$138.25M$134.52M$130.16M$123.58M$129.24M$134.40M$130.58M$129.64M$128.21M
    Gross profit$23.26M$23.24M$19.72M$25.07M$26.03M$22.79M$20.40M$19.37M$23.92M$23.88M$21.21M$26.69M
    Operating income$11.99M$9.15M$1.89M$16.07M$20.93M$15.29M$4.42M$14.17M$19.80M$16.01M$8.57M$14.58M
    Net income$5.44M$5.96M-$789.00K$4.95M$14.24M$10.64M-$154.00K$7.40M$11.74M$9.03M$3.22M$2.20M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $121.71M exceeded cash and equivalents by $99.01M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$584.01M$590.41M$586.39M$578.35M$580.85M$568.58M$774.67M$648.83M$584.81M$573.05M
    Current assets$214.66M$226.61M$223.14M$211.70M$189.06M$165.85M$221.24M$230.98M$207.43M$186.46M
    Cash and equivalents$22.70M$19.16M$15.12M$15.43M$17.70M$13.81M$11.09M$13.12M$14.40M$14.76M
    Total liabilities$311.80M$332.67M$356.59M$389.40M$419.85M$493.01M$592.53M$487.93M$436.08M$417.75M
    Short-term debt$11.46M$10.69M$10.18M$11.70M$12.34M$11.44M$11.84M$10.40M$17.07M$15.69M
    Long-term debt$110.25M$126.11M$163.13M$172.39M$188.64M$259.43M$305.28M$289.77M$226.99M$216.49M
    Shareholder equity$265.99M$251.99M$224.81M$184.26M$156.45M$71.51M$177.87M$160.90M$148.73M$155.30M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$593.52M$586.78M$587.73M$584.01M$591.36M$602.11M$591.52M$590.41M$600.47M$597.80M$587.95M$586.39M
    Total liabilities$309.43M$308.01M$312.58M$311.80M$313.97M$334.81M$332.16M$332.67M$344.05M$352.11M$350.53M$356.59M
    Cash and equivalents$21.38M$22.73M$22.82M$22.70M$25.63M$31.19M$22.11M$19.16M$21.47M$17.70M$14.91M$15.12M
    Shareholder equity$277.97M$272.67M$268.89M$265.99M$271.35M$261.28M$253.39M$251.99M$250.74M$240.27M$232.16M$224.81M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 60.2% of operating cash flow. Dividends came to 8.4% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow$37.03M$56.39M$24.79M$24.96M$36.58M$57.87M$89.53M$111.83M$124.27M$131.89M
    Capital expenditures$14.74M$13.03M$10.58M$10.22M$13.54M$11.88M$22.27M$21.74M$18.77M$11.70M
    Free cash flow$22.29M$43.36M$14.21M$14.74M$23.04M$45.99M$67.26M$90.09M$105.50M$120.18M
    Dividends paid$1.87M$1.88M$1.87M$1.85M$1.83M$12.45M$97.57M$97.25M$97.14M$95.14M
    Investing cash flow-$2.23M-$6.39M-$6.65M-$3.86M-$10.22M$7.85M-$5.68M-$70.64M-$20.56M-$14.72M
    Financing cash flow-$31.25M-$45.96M-$18.45M-$23.38M-$22.46M-$63.01M-$85.87M-$42.47M-$104.08M-$124.90M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$4.97M$7.81M$3.96M$7.95M$8.50M$13.92M$6.66M$20.61M$13.10M$17.15M$5.53M$19.43M
    Capital expenditures$10.66M$5.77M$4.89M$3.80M$3.03M$4.33M$3.58M$4.38M$2.73M$2.87M$3.06M$2.58M
    Free cash flow-$5.69M$2.04M-$926.00K$4.15M$5.47M$9.60M$3.08M$16.23M$10.37M$14.28M$2.48M$16.85M
    Last 12 quarters

    Frequently Asked Questions About CLB

    What is Core Laboratories NV's annual revenue?

    Core Laboratories NV reported revenue of $526.52M for the fiscal year ended Dec 31, 2025.

    How fast is Core Laboratories NV's revenue growing?

    Revenue was up 0.5% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 2.4%.

    Is Core Laboratories NV profitable?

    Yes. Core Laboratories NV reported net income of $29.67M for the fiscal year ended Dec 31, 2025, with a net margin of 5.6%.

    How much free cash flow does CLB generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $37.03M minus capital expenditures of $14.74M produced free cash flow of $22.29M.

    How much debt does Core Laboratories NV have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $110.25M, short-term debt of $11.46M and cash and equivalents of $22.70M.